OPEN MARKET SALES AGREEMENT1Open Market Sales Agreement • August 8th, 2023 • Recursion Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
Recursion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell from time to time through Jefferies LLC, as sales agent and/or principal (the “Agent”), shares of the Company’s Class A common stock, par value $0.00001 per share (the “Class A Common Shares”), having an aggregate offering price of up to $300,000,000 on the terms set forth in this sales agreement (this “Agreement”). The Class A Common Shares and the shares of the Company’s Class B common stock, par value $0.00001 per share, are referred to herein as the “Common Stock.”
May 19, 2023 David Mauro Re: Employment Offer LetterEmployment Agreement • August 8th, 2023 • Recursion Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Utah
Recursion Pharmaceuticals, Inc. (the “Company,” “we,” “us,” or “our”) is truly excited to extend you an offer on the terms and conditions in this letter agreement (the “Agreement”) and hope that you will be joining us in our mission of decoding biology to radically improve lives.
